These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 29787664)
21. [Effects of the new peptide anxiolytic drug selank on the cardiovascular system functioning and respiration in cats]. Gan'shina TS; Kozlovskiĭ II Eksp Klin Farmakol; 2005; 68(4):33-5. PubMed ID: 16193654 [TBL] [Abstract][Full Text] [Related]
22. [Peptidergic modulation of the hippocampus synaptic activity]. Skrebitskiĭ VG; Kondratenko RV; Povarov IS; Dereviagin VI Ross Fiziol Zh Im I M Sechenova; 2011 Nov; 97(11):1169-78. PubMed ID: 22390072 [TBL] [Abstract][Full Text] [Related]
23. [Effects of piracetam and meclofenoxate on the brain NMDA and nicotinic receptors in mice with different exploratory efficacy in the cross maze test]. Kovalev GI; Firstova IuIu; Salimov RM Eksp Klin Farmakol; 2008; 71(1):12-7. PubMed ID: 18365480 [TBL] [Abstract][Full Text] [Related]
24. [Effect of new synthetic anxiolytic selank on gastric wall blood flow and mesenteryc lymphatic vessels contractility in anesthetized rats]. Pavlov TS; Sanzhieva LTs; Samonina GE; Sergeev VI; Lelekova TV Ross Fiziol Zh Im I M Sechenova; 2005 Feb; 91(2):178-83. PubMed ID: 15835541 [TBL] [Abstract][Full Text] [Related]
25. [Experimental optimization of learning and memory processes by selank]. Semenova TP; Kozlovskiĭ II; Zakharova NM; Kozlovskaia MM Eksp Klin Farmakol; 2010 Aug; 73(8):2-5. PubMed ID: 20919548 [TBL] [Abstract][Full Text] [Related]
26. [Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia]. Zozulia AA; Neznamov GG; Siuniakov TS; Kost NV; Gabaeva MV; Sokolov OIu; Serebriakova EV; Siranchieva OA; Andriushenko AV; Telesheva ES; Siuniakov SA; Smulevich AB; Miasoedov NF; Seredenin SB Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(4):38-48. PubMed ID: 18454096 [TBL] [Abstract][Full Text] [Related]
27. [A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders]. Medvedev VE; Tereshchenko ON; Israelian AIu; Chobanu IK; Kost NV; Sokolov OIu; Miasoedov NF Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(7):17-22. PubMed ID: 25176261 [TBL] [Abstract][Full Text] [Related]
28. Relations between open-field, elevated plus-maze, and emergence tests in C57BL/6J and BALB/c mice injected with GABA- and 5HT-anxiolytic agents. Lalonde R; Strazielle C Fundam Clin Pharmacol; 2010 Jun; 24(3):365-76. PubMed ID: 19735300 [TBL] [Abstract][Full Text] [Related]
29. [Compensatory and antiamnestic effects of heptapeptide Selank in monkeys]. Zh Evol Biokhim Fiziol; 2008; 44(3):284-90. PubMed ID: 18727417 [TBL] [Abstract][Full Text] [Related]
30. Selank and short peptides of the tuftsin family in the regulation of adaptive behavior in stress. Kozlovskaya MM; Kozlovskii II; Val'dman EA; Seredenin SB Neurosci Behav Physiol; 2003 Nov; 33(9):853-60. PubMed ID: 14969422 [TBL] [Abstract][Full Text] [Related]
31. Role of ventral hippocampal GABA(A) and NMDA receptors in the anxiolytic effect of carbamazepine in rats using the elevated plus maze test. Rezvanfard M; Zarrindast MR; Bina P Pharmacology; 2009; 84(6):356-66. PubMed ID: 19907194 [TBL] [Abstract][Full Text] [Related]
32. High dose of simvastatin induces hyperlocomotive and anxiolytic-like activities: The association with the up-regulation of NMDA receptor binding in the rat brain. Wang Q; Zengin A; Deng C; Li Y; Newell KA; Yang GY; Lu Y; Wilder-Smith EP; Zhao H; Huang XF Exp Neurol; 2009 Mar; 216(1):132-8. PubMed ID: 19100736 [TBL] [Abstract][Full Text] [Related]
33. Expression of inflammation-related genes in mouse spleen under tuftsin analog Selank. Kolomin T; Shadrina M; Andreeva L; Slominsky P; Limborska S; Myasoedov N Regul Pept; 2011 Oct; 170(1-3):18-23. PubMed ID: 21609736 [TBL] [Abstract][Full Text] [Related]
34. The inhibitory effect of Selank on enkephalin-degrading enzymes as a possible mechanism of its anxiolytic activity. Zozulya AA; Kost NV; Yu Sokolov O; Gabaeva MV; Grivennikov IA; Andreeva LN; Zolotarev YA; Ivanov SV; Andryushchenko AV; Myasoedov NF; Smulevich AB Bull Exp Biol Med; 2001 Apr; 131(4):315-7. PubMed ID: 11550013 [TBL] [Abstract][Full Text] [Related]
35. Strain-dependent hippocampal protein levels of GABA(B)-receptor subunit 2 and NMDA-receptor subunit 1. Sunyer B; An G; Kang SU; Höger H; Lubec G Neurochem Int; 2009 Sep; 55(4):253-6. PubMed ID: 19524116 [TBL] [Abstract][Full Text] [Related]
36. Behavioural pharmacology of the α5-GABA Gacsályi I; Móricz K; Gigler G; Wellmann J; Nagy K; Ling I; Barkóczy J; Haller J; Lambert JJ; Szénási G; Spedding M; Antoni FA Neuropharmacology; 2017 Oct; 125():30-38. PubMed ID: 28694097 [TBL] [Abstract][Full Text] [Related]
37. [Nootropic and analgesic effects of Semax following different routes of administration]. Manchenko DM; Glazova NIu; Levitskaia NG; Andreeva LA; Kamenskiĭ AA; Miasoedov NF Ross Fiziol Zh Im I M Sechenova; 2010 Oct; 96(10):1014-23. PubMed ID: 21268834 [TBL] [Abstract][Full Text] [Related]
38. Anxiolytic-like effects of NMDA/glycine-B receptor ligands are abolished during the elevated plus-maze trial 2 in rats. Bertoglio LJ; Carobrez AP Psychopharmacology (Berl); 2003 Dec; 170(4):335-42. PubMed ID: 13680083 [TBL] [Abstract][Full Text] [Related]
39. Involvement of NMDA receptor in low-frequency magnetic field-induced anxiety in mice. Salunke BP; Umathe SN; Chavan JG Electromagn Biol Med; 2014 Dec; 33(4):312-26. PubMed ID: 24131395 [TBL] [Abstract][Full Text] [Related]
40. Administration of riluzole into the basolateral amygdala has an anxiolytic-like effect and enhances recognition memory in the rat. Sugiyama A; Saitoh A; Yamada M; Oka JI; Yamada M Behav Brain Res; 2017 Jun; 327():98-102. PubMed ID: 28359884 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]